Keywords: ASCVD, atherosclerotic cardiovascular disease; BRCA; CAC, coronary artery calcium; CVD, cardiovascular disease; FAP, familial adenomatous polyposis; NSAID, nonsteroidal anti-inflammatory drug; cardio-oncology; cardiovascular risk assessment; prevention.